"iDoctor – Medical Blog"

WHEELING, W.Va. (MedPage Today) — Golimumab, a monoclonal antibody targeting tumor necrosis factor-alpha administered subcutaneously, bested placebo in relieving psoriatic arthritis symptoms in a phase III randomized trial.

This entry was posted on Thursday, June 4th, 2009 at 8:29 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.